Ximedica

Antibiotic Susceptibility Testing

Converting existing technologies to meet critical needs in infectious disease testing

Background:

LifeScale® AST ​
Affinity Biosensors

Need:

Adapt Affinity’s unique particle metrology technology for the microbiology market to address rapid diagnosis and selection of appropriate antibiotic therapy. ​

Solution:

Ximedica provided a solution to the automation of the assay workflow through our AsysTek™ robotics engine along with deep experience in system architecture, while Affinity supplied its unique MEMS technology and focus on the microbiology applications.​

Result:

Ximedica and Affinity produced fully functional clinical trial units under strictly regimented ISO-13485 design controls. The new LifeScale platform offers several key benefits over optical density measurement of microbes. These include ultra-high resolution of mass, detection of growth at lower concentrations, and elimination of measurement anomalies associated with microbe labels or surface binding.​

The latest in MedTech & Diagnostics straight to your inbox

Stay Informed

At Ximedica, our people define who we are.

More About Our People

Marco Flavio Marinucci

Marco Flavio Marinucci

Director of Digital Products

John Ristuccia

John Ristuccia

Program Manager

Andre LaFreniere

Andre LaFreniere

VP, Business Development

Sean Kienle

Sean Kienle

Mechanical Engineer

Jimmy Wong

Jimmy Wong

Information Designer & Human Centered Industrial Designer

Michelle Wu

Michelle Wu

VP, Quality